Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

• by Rachael A. Gordon, Sara S. McCoy

• July 1, 2026

Trial Exclusions May Skew RA Drug Comparisons

Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.

• by Andrea Surnit

• June 12, 2026

• 5 min

Genistein in autoimmune diseases: from experimental evidence to emerging clinical data

• by Stefan Tukaj

• July 6, 2026

Musculoskeletal ultrasound discriminating camptodactyly-arthropathy-coxa vara-pericarditis syndrome and juvenile idiopathic arthritis

• by Hatice Adigüzel Dundar, Faekah Gohar, Daniel Windschall

• June 4, 2026